Loading…
COVONIA MEDICATED SORE THROAT is a brand name for Chlorhexidine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Symptomatic and local treatment at the pharynx. Proposed as disinfectant and local pain-killer of sore throat and disorders of the pharynx and mouth accompanied by irritation, the presence of lidocaine causes a quick alleviation of the symptoms. In case of a bacterial infection accompanied by fever, a supplementary…
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults: 6 to 10 tablets per day, to melt slowly in the mouth. Children from 12 years old: half dose. This medicine is intended as symptomatic treatment and should not be used on a long-term basis. If there is no improvement within 3 to 4 days of treatment, it is advisable to consult a doctor.
Method of administration Oromucosal use
Side effects are classified according to organ system with evaluation of the frequency according to the following convention: very common (≥ 1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1000, < 1/100), rare (≥ 1/10000, < 1/1000), very rare (<1/10000), not known (cannot be estimated from the available data).
Nervous System Disorders Common:
Oral paraesthesia/hypoaesthesia Immune system disorders (frequency not known) It should be taken into account that rare allergic reactions of the skin and mucous membrane, which are caused by contact with anaesthetics of the amide-type, such as lidocaine can occur: cases of dermatitis and rashes, which were caused by this product in other circumstances, have been described.
Anaphylactic reactions may occur. Taste disorders, and a burning feeling on the tongue may occur. Prolonged and continuous use of chlorhexidine can cause brown- discoloration of the teeth. However, this brown-discoloration is removable.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for “MHRA Yellow Card” in the Google Play or Apple App Store.
Disinfecting substances do not make sterile; they temporarily reduce the number of micro- organisms at the oral cavity and pharynx. Restrict the use of this medicine to the necessary alleviation of the existing pain and irritation. It must not be administered on a long term basis, in an uninterrupted or repeated manner.
Avoid the use of this medicine in persons with extreme allergic predisposition. The use of a too high dose (more than 20 tablets per day) can cause a small risk on too great insensitivity of the glottis area, which can cause a diminished control on the swallowing reflex and food aspiration in the airways can occur.
Covonia Lozenges Lemon contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. The additive effect of concomitantly administered products containing sorbitol (fructose) and dietary intake of sorbitol (fructose) should be taken into account.
The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly. Covonia Lozenges Lemon also contains aspartame. This contains a source of phenylalanine and may be harmful for people with phenylketonuria.
Aspartame is hydrolysed in the gastrointestinal tract when orally ingested. One of the major hydrolysis products is phenylalanine.
Children younger than 12 years old. 1, and in particular to local anaesthetics such as lidocaine.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Chlorhexidine in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.